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Abstract
Actinobacillus pleuropneumoniae (A. pleuropneumoniae) causes fibrino-hemorrhagic necrotizing pleuropneumonia in
pigs. Production of proinflammatory mediators in the lungs is an important feature of A. pleuropneumoniae
infection. However, bacterial components other than lipopolysaccharide involved in this process remain
unidentified. The goals of this study were to determine the role of A. pleuropneumoniae exotoxin ApxI in cytokine
induction and to delineate the underlying mechanisms. Using real-time quantitative PCR analysis, we found native
ApxI stimulated porcine alveolar macrophages (PAMs) to transcribe mRNAs of IL-1b, IL-8 and TNF-a in a
concentration- and time-dependent manner. Heat-inactivation or pre-incubation of ApxI with a neutralizing
antiserum attenuated ApxI bioactivity to induce cytokine gene expression. The secretion of IL-1b, IL-8 and TNF-a
protein from PAMs stimulated with ApxI was also confirmed by quantitative ELISA. In delineating the underlying
signaling pathways contributing to cytokine expression, we observed mitogen-activated protein kinases (MAPKs)
p38 and cJun NH2-terminal kinase (JNK) were activated upon ApxI stimulation. Administration of an inhibitor
specific to p38 or JNK resulted in varying degrees of attenuation on ApxI-induced cytokine expression, suggesting
the differential regulatory roles of p38 and JNK in IL-1b, IL-8 and TNF-a production. Further, pre-incubation of
PAMs with a CD18-blocking antibody prior to ApxI stimulation significantly reduced the activation of p38 and JNK,
and subsequent expression of IL-1b, IL-8 or TNF-a gene, indicating a pivotal role of b2 integrins in the ApxI-
mediated effect. Collectively, this study demonstrated ApxI induces gene expression of IL-1b, IL-8 and TNF-a in
PAMs that involves b2 integrins and downstream MAPKs.
Introduction
Actinobacillus pleuropneumoniae (A. pleuropneumoniae)
is the etiological agent of porcine pleuropneumonia
characterized as an exudative, fibrinous, hemorrhagic,
and necrotizing pneumonia along with pleuritis [1].
Multiple factors of A. pleuropneumoniae including lipo-
polysaccharide (LPS), A. pleuropneumoniae exotoxins
(Apx), polysaccharide capsule and etc. may contribute to
the disease [2-5]. Among these, Apx toxins are the
major virulence factors involved in the pathogenesis of
pleuropneumonia [6]. For the Apx toxins (ApxI to IV)
identified so far, ApxI elicits its most significant effects
on hemolysis and cytolysis [7].
Apx toxins are members of the “Repeats in Toxin”
(RTX) family that are widespread in Pasteurellaceae which
cause infectious diseases, most often in animals but also in
humans [8]. RTX toxins display a cytotoxic and/or a
hemolytic activity [8]. In addition, Mannheimia haemoly-
tica RTX leukotoxin (Lkt) has been identified as a potent
inducer on the gene expression of proinflammatory cyto-
kines such as tumor necrosis factor alpha (TNF-a), inter-
leukin (IL)-1, and IL-8 in bovine alveolar macrophages
[9,10]. There is compelling evidence that pigs naturally or
experimentally infected by A. pleuropneumoniae show
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significantly increased expression of cytokines IL-1, IL-6,
IL-8 and TNF-a in lungs [4,5,11]. A study on porcine
alveolar macrophages indicated multiple components of
A. pleuropneumoniae, e.g., killed bacteria, bacterial culture
supernatant, crude surface extract, or lipopolysaccharide
(LPS), are potent stimulants for IL-1, IL-8 and TNF-a
expression [3]. However, up to now, the role of Apx
toxins in proinflammatory cytokine expression remains
unidentified.
The b2 integrins have been identified to serve as a
receptor for RTX toxins such as leukotoxin of Aggregati-
bacter actinomycetemcomitans, a-hemolysin of Escheri-
chia coli, and Lkt of M. haemolytica [12-15].
b2 integrins consist of four members including leuko-
cyte function-associated antigen 1 (LFA-1; CD11a/
CD18), Mac-1 (CD11b/CD18), p150,95 (CD11c/CD18),
and adb2 (CD11d/CD18), that play important roles in
cell-matrix interaction and immune response [16].
M. haemolytica Lkt-induced cytotoxic effect on bovine
leukocytes can be blocked by an antibody specific
to ruminant CD18, suggesting a role of CD18 in
Lkt-mediated cytolysis [13,15,17]. Moreover, in bovine
alveolar macrophages, Lkt-induced intracellular [Ca2+]
elevation, which is important for proinflammatory cyto-
kine gene expression, depends on LFA-1 [9,14,18]. A
recent study on ApxIII toxin revealed porcine, but not
bovine or human, CD18 is necessary for mediating
ApxIII-induced leukolysis [19], providing another exam-
ple of a species-specific effect of RTX using the
CD18 subunit of b2 integrins.
The mitogen-activated protein kinases (MAPKs) are a
family of serine/threonine protein kinases that are
important regulators in a variety of cellular activities
[20]. A plethora of studies have revealed proinflamma-
tory cytokines are regulated by MAPKs, such as p38,
cJun NH2-terminal kinase (JNK), and extracellular sig-
nal-regulated kinase (ERK) [21-25]. Since production of
proinflammatory cytokines in lungs is an important
defense mechanism in response to pathogens [26], the
goals of this study were to examine the effect of ApxI
on cytokine expression in PAMs and to determine the
potential involvement of MAPKs and b2 integrins in
this event.
Materials and methods
Chemicals, reagents and antibodies
Brain-heart infusion (BHI) was from Becton, Dickinson
and Company (Franklin Lakes, NJ, USA). The nicotina-
mide adenine dinucleotide (NAD), polymyxin B, 2,3-bis
(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide inner salt (XTT), trypan blue, and anti-b-
actin antibody were from Sigma Aldrich (Saint Louis,
MO, USA). The p38 inhibitor SB203580 and JNK inhibi-
tor SP600125 were from Calbiochem (Darmstadt,
Germany). Antibody specific to active, phosphorylated
p38 or JNK was from Promega (Madison, WI, USA). A
blocking antibody specific to porcine CD18 was pur-
chased from SeroTec (Kidlington, Oxfordshire, United
Kingdom).
Cell culture
Porcine alveolar macrophages (PAMs) were obtained
from 3- to 6- week old healthy piglets through lavage
and stored in liquid nitrogen using previously
described procedures [27]. Piglets were euthanized
according to the protocol approved by the Institutional
Animal Care and Use Committee (IACUC) of National
Chung Hsing University. For the experiments, PAMs
were thawed, resuspended in culture medium RPMI-
1640 supplemented with 10% fetal bovine serum (FBS),
2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/
mL streptomycin (Invitrogen, Carlsbad, CA, USA) and
seeded into cell culture plates as indicated below.
ApxI exotoxin preparation
Actinobacillus pleuropneumoniae serotype 10 (strain
13039) was a kind gift from the Animal Health Research
Institute, Council of Agriculture, Republic of China. It
secretes only ApxI but not ApxII and ApxIII [28]. Pre-
paration of the ApxI was performed according to the
procedures described previously [27]. Briefly, colonies of
A. pleuropneumoniae serotype 10 on BHI agar plates
containing 10 μg/mL NAD were transferred to BHI
broth supplemented with 10 μg/mL NAD and cultured
at 37°C for 5 h. The BHI broth was then replaced by
RPMI-1640 supplemented with 2% FBS and 10 mM
CaCl2 and cultivated for an additional 2 h. Subsequently,
the bacterial culture supernatant was collected by centri-
fugation at 16 000 × g for 10 min at 4°C followed by
passage through a filter with pore-size of 0.45 μm. The
filtered preparation containing native exotoxin ApxI was
aliquoted and stored at -70°C for further experiments.
The cytotoxic activity of ApxI was determined using an
XTT assay as described previously [29]. One cytotoxic
unit (CU) of ApxI was defined as the quantity of toxin
causing a 50% reduction in mitochondrial activity of 2 ×
105 PAMs.
Determination of LPS content in the exotoxin preparation
Limulus amebocyte lysate test (Cambrex Bio Science,
Walkersville, MD, USA) was performed according to the
manufacturer’s instructions. It was found that the pre-
paration containing 1 CU/mL ApxI had a level of
307 endotoxin units (EU)/mL. To minimize the effect of
contaminating LPS in the exotoxin preparation, poly-
myxin B was added to a final concentration of 10 μg/
mL throughout the study except where indicated
otherwise.
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Treatment with ApxI, drugs, and antibody
PAMs were seeded to 35-mm tissue culture plates at a
density of 2 × 106 cells/plate in culture medium and
incubated at 37°C in 5% CO2 overnight. Cells were
washed once and replenished with low serum medium
(LSM; RPMI-1640 supplemented with 1% FBS, 2 mM
L-glutamine, 100 U/mL penicillin, and 100 μg/mL strep-
tomycin) containing 0-2 CU/mL of ApxI and incubated
for 0-12 h as indicated elsewhere. To abolish the bioac-
tivity of ApxI, exotoxin was incubated at 98°C for 1 h or
pre-incubated with 20 μg/mL antiserum raised against a
recombinant subunit ApxI protein for 30 min at 37°C
prior to applying to PAMs in the indicated experiments
[27]. In experiments examining the roles of mitogen-
activated protein kinases (MAPKs) and b2 integrins on
ApxI-induced cytokine expression, PAMs were incu-
bated with LSM containing 10 μM p38 inhibitor
SB203580, 10 μM JNK inhibitor SP600125, or 5-10 μg/
mL anti-porcine CD18 antibody for 1 h prior to stimula-
tion with 0.5 CU/mL of ApxI.
Real-time quantitative PCR (RT-qPCR)
The levels of cytokine mRNA in PAMs were evaluated
by RT-qPCR at 2 h post ApxI stimulation as described
above. Total RNA of PAMs was extracted using High
Pure RNA Isolation Kit (Roche Applied Science, Man-
nheim, Germany) according to the manufacturer’s
instructions. cDNA synthesis and RT-qPCR analysis
were performed as follows.
cDNA synthesis
Total RNA extracted from PAMs was quantified by
detection of light absorption at 260 nm using a Nano-
Vue instrument (GE Healthcare Bio-Sciences Corp,
Piscataway, NJ, USA) and ~1 μg of RNA was used for
cDNA synthesis. To prepare a 20 μL reaction solution,
RNA was mixed with 0.5 μg Oligo(dT)15 primer (Pro-
mega) in each PCR tube and incubated at 65°C for
10 min to ensure the denaturation of the RNA second-
ary structures. Subsequently, the tube was immediately
placed on ice prior to adding 20 U RNasin® ribonu-
clease inhibitor (Promega), 20 nmole dNTP, and 10 U
Transcriptor Reverse Transcriptase with 1 × reaction
buffer (Roche Applied Science), and a final volume
adjusted to 20 μL with distilled water. cDNA synthesis
was carried out at 55°C for 30 min and the activity of
reverse transcriptase was inactivated by heating the solu-
tion to 85°C for 5 min. In this study, a 10-fold dilution
of the synthesized cDNA was used as a template for
RT-qPCR analysis.
Oligonucleotide primers
The sequences of oligonucleotide primers used in this
study are listed in Table 1. Primers for interleukin-
1 beta (IL-1b), tumor necrosis factor alpha (TNF-a),
and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) genes were designed based on porcine cyto-
kine sequences obtained from the National Center for
Biotechnology Information (NCBI) using Lasergene soft-
ware version 5.07 (DNASTAR Inc, Madison, WI, USA).
Primers for IL-8 gene were synthesized according to
Cho et al. [30].
Real-time quantitative PCR amplification
Real-time PCR amplification was performed using the
LightCycler® 480 SYBR green I master with a LightCy-
cler® 480 instrument (Roche Applied Science). Briefly,
to prepare the 2 × master mix, primers of the target
gene were added into the LightCycler® 480 SYBR green
I master to a concentration of 0.4 μM. Five microliters
of 2 × master mix was further aliquoted to every well of
the 96-well reaction plate, followed by addition of 5 μL
of the cDNA sample. The reactions were carried out as
an initial pre-incubation at 95°C for 5 min, followed by
45 amplification cycles of: 95°C for 10 s, 58°C or 48°C
for 10 s, and 72°C for 15 s. Melting curve analysis was
performed immediately after amplification from 65 to
95°C with continuous fluorescence acquisition. In each
reaction, the cycle number at which the fluorescence
rises appreciably above the background fluorescence is
determined as crossing point (CP). In this study, the
background fluorescence and the CP values are automa-
tically calculated by the software (version 1.5).
Calculation of relative gene expression
The level of cytokine gene expression was analyzed
using the “Delta-delta method” for relative quantification
[31]. The expression of the selected cytokine gene was
normalized to that of the reference GAPDH gene using
the equation 2-[ΔCP sample - ΔCP control] = 2-ΔΔCP and
further converted to relative mRNA expression. In
experiments assessing the kinetics of ApxI on cytokine
gene expression, the relative mRNA expression was
further normalized to the percent of cell survival at each
time point.
Determination of the protein levels of cytokines
To quantify the protein levels of cytokines, 2 ×
106 PAMs were stimulated with 1 CU/mL of ApxI for
4 h. In the inhibitor experiments, 1 × 106 PAMs were
incubated with 0.5 CU/mL ApxI for 8 h. After treat-
ments, culture supernatants were collected following
centrifugation at 700 × g for 10 min. The levels of cyto-
kines IL-1b, IL-6, IL-8, and TNF-a in the culture super-
natants were determined by quantitative DuoSet® ELISA
kits (R&D Systems, Minneapolis, MN, USA) according
to the manufacturer’s instructions.
Trypan blue exclusion test
The survival rate of PAMs was assessed using a trypan
blue exclusion test [32]. Briefly, after ApxI treatment,
PAMs were collected by trypsinization, stained with
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0.1% trypan blue, and observed using a microscope.
Cells stained blue were scored as non-viable. At least
500 cells were counted for each treatment of at least tri-
plicate determinations. Percent of cell survival was cal-
culated as follow: 100 × [1 - (% cell death at each time
point - % cell death at 0 h)].
Western blot analysis
In experiments examining MAPK activation, 2 × 106 cells
PAMs in 35-mm tissue culture plates were stimulated
with 0.5 CU/mL ApxI for 1 h. Thereafter, cells were
washed once with ice-cold phosphate buffered saline
(PBS) and lysed in a lysis buffer (1% Triton X-100, 20 mM
Tris-Cl, 137 mM NaCl, 25 mM b-glycerophosphate,
2 mM NaPPi, 1 mM Na3VO4, 10% glycerol, 2 mM EDTA,
10 μM leupeptin, 0.77 μM aprotinin, 0.5 mM DTT,
10 mM PMSF, and 2 mM benzamidine; pH 7.4) [33]. Cell
lysates were centrifuged at 15 000 × g for 10 min and
supernatants harvested. The protein concentration of the
cell lysate was determined using the Bradford assay (Bio-
Rad Laboratories, Hercules, CA, USA). Twenty to thirty
μg of each lysate was analyzed by Western blot analysis
using an antibody specific to active, phosphorylated p38 or
JNK. Immunoblots were reprobed with an anti-b-actin
antibody as a loading control. The intensity of the active
p38 or JNK was quantified using ImageJ software, version
1.37v (National Institutes of Health), and normalized to
the intensity of the loading control b-actin.
Statistical analysis
Data were obtained from three independent experiments
of at least triplicate determinations. Statistical analysis
was performed using one-way analysis of variance
(ANOVA). The error bars represent the standard error
of mean (SEM).
Results
Actinobacillus pleuropneumoniae ApxI induces expression
of proinflammatory cytokine genes in porcine alveolar
macrophages
To evaluate the effect of A. pleuropneumoniae serotype
10-derived ApxI on proinflammatory cytokine gene
expression, porcine alveolar macrophages (PAMs) were
incubated with 0-2 CU/mL of ApxI for 2 h and sub-
jected to real-time quantitative PCR (RT-qPCR) analysis.
Significant elevation of mRNA levels of IL-1b, IL-8 and
TNF-a was noted in PAMs treated with 0.2 to 2 CU/
mL of ApxI (p < 0.001) (Figure 1A). The levels of cyto-
kine mRNA increased as the concentration of ApxI
elevated to 1 CU/mL, indicating a concentration-depen-
dent effect of ApxI. Substantial levels of mRNA expres-
sion were noted in cells treated with ≥ 0.5 CU/mL
(Figure 1A). In subsequent experiments, ApxI at 0.5 or
1 CU/mL was used throughout.
In addition, cytokine expression was compared in the
absence and presence of an LPS-blocker polymyxin
B (PMB). It was noted that 1 CU/mL ApxI preparation
without PMB elicited mRNA expression of IL-1b, IL-8,
and TNF-a at a level ~8-, 2-, and 13-fold higher than
that treated with ApxI in the presence of PMB, respec-
tively (Figure 1A).
To assess the kinetics of ApxI on proinflammatory
cytokine gene expression, PAMs were treated with
1 CU/mL of ApxI for varied time periods and mRNA
levels were evaluated using RT-qPCR. The mRNA levels
of IL-1b, IL-8 and TNF-a elevated at 1 h following
ApxI treatment (Figure 1B). The maximal levels of
mRNA expression of all three cytokines were observed
at 4 h. At 8 or 12 h, the mRNA levels of all these cyto-
kines were less than 63% of the maximal levels
(Figure 1B). Collectively, these findings demonstrate
A. pleuropneumoniae serotype 10-derived ApxI induces
IL-1b, IL-8 and TNF-a gene expression in PAMs in a
concentration- and time-dependent manner.
Exotoxin-induced proinflammatory cytokine gene
expression is attributed to ApxI bioactivity
To demonstrate cytokine gene expression in PAMs is
truly attributable to the bioactivity of ApxI, ApxI was
heat-inactivated (ΔApxI) or pre-incubated with an anti-
serum raised against a recombinant subunit ApxI pro-
tein [27] before application to PAMs and subjected to
RT-qPCR analysis. PAMs treated with ΔApxI had
mRNA level of IL-1b, IL-8 or TNF-a that was not
Table 1 Oligonucleotide primers used in this study
Genes Sequences (5’®3’) Amplicon size (bp) Annealing temperature (°C) Accession No. or reference
IL-1b Forward: GCAGTGGAGAAGCCGATGAAGA 199 58 NM_214055
Reverse: GGCCAGCCAGCACTAGAGATTTG
IL-8 Forward: TTTCTGCAGCTCTCTGTGAGG 269 48 [30]
Reverse: CTGCTGTTGTTGTTGCTTCTC
TNF-a Forward: CGCATCGCCGTCTCCTACCA 202 58 NM_214022
Reverse: GCCCAGATTCAGCAAAGTCCAGAT
GAPDH Forward: GGCTGCCCAGAACATCATCC 195 58 AF309651
Reverse: GACGCCTGCTTCACCACCTTCTTG
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significantly different from cells without treatment
(Figure 2). Moreover, PAMs treated with serum-neutra-
lized ApxI showed a 70-84% attenuation in IL-1b, IL-
8 or TNF-a mRNA expression level, indicating IL-1b,
IL-8 or TNF-a gene expression is ascribed to the bioac-
tivity of ApxI.
To confirm the effects of ApxI on the protein level of
cytokine induction, PAMs were incubated with 1 CU/
mL ApxI for 4 h and cell culture supernatants analyzed
using quantitative ELISA. Incubation of ApxI resulted in
secretion of ~650 pg/mL of IL-1b, 30 ng/mL of IL-8,
and 3.2 ng/mL of TNF-a from PAMs (Figure 3). Cells
stimulated with ΔApxI had a level of 84 pg/mL of IL-1b
in culture supernatant that was not significantly
different from cells without treatment (Figure 3A).
A similar pattern was also observed for the protein
levels of IL-8 and TNF-a in cells treated with ΔApxI
and non-treated cells (Figures 3B and 3C). Interestingly,
only the basal level (~120 pg/mL) of IL-6 was detected
Figure 1 A. pleuropneumoniae exotoxin ApxI induces IL-1b, IL-8
and TNF-a mRNA expression of porcine alveolar macrophages
(PAMs) in a concentration- and time-dependent manner. (A)
PAMs were stimulated with 0-2 CU/mL ApxI in the presence (w/) or
absence (w/o) of polymyxin B (PMB) for 2 h. Total RNA of PAMs was
extracted for cDNA synthesis and subjected to RT-qPCR. (B) PAMs
were treated with 1 CU/mL ApxI in the presence of PMB for 0-12 h
and subjected to RT-qPCR. The expression levels of cytokines were
further normalized to corresponding survival rate of PAMs at each
time point. Data are representative of three independent
experiments of at least triplicate determinations. The error bars are
SEM.
Figure 2 Bioactivity of ApxI is required for induction of
proinflammatory cytokine gene expression. PAMs were treated
with 0.5 CU/mL of ApxI, heat-inactivated ApxI (Δ), or ApxI pre-
incubated with an antiserum raised against recombinant subunit
ApxI protein (rA). Medium without ApxI toxin served as a negative
control (C). Two hours after stimulation, the total RNA of PAMs was
extracted for RT-qPCR analysis. Data are representative of three
independent experiments of at least triplicate determinations.
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in ApxI-treated PAMs, which was similar to that in cells
without treatment or treated with ΔApxI (Figure 3D).
Involvement of mitogen-activated protein kinases
(MAPKs) in ApxI-induced proinflammatory cytokine gene
expression
A plethora of studies indicate members of MAPK family
play important roles in proinflammatory cytokine induc-
tion [21-25]. These findings prompted us to examine
the roles of MAPK members p38 and JNK in ApxI
effect. PAMs stimulated with 0.5 CU/mL of ApxI for
1 h were subjected to Western blot analysis for active
p38 and JNK. ApxI treatment induced an appreciable
increase in both active, phosphorylated p38 and JNK in
PAMs (Figure 4A). Low levels of phosphorylated
p38 were noted in cells treated with ΔApxI that did not
significantly differ from non-treated control cells, and
there was no detectable phosphorylated JNK in ΔApxI-
treated or control cells, suggesting the activation of JNK
and p38 MAPK is attributable to ApxI.
To further assess the role of p38 or JNK in ApxI-
induced cytokine expression, PAMs were pre-treated
with an inhibitor specific to p38 (SB20358) or JNK
(SP600125), or vehicle DMSO for 1 h, followed by sti-
mulation with 0.5 CU/mL ApxI for 2 h, and subjected
to RT-qPCR analysis. Treatment of p38 inhibitor prior
to ApxI stimulation significantly attenuated IL-1b
mRNA level by 83%. However, the JNK inhibitor
did not attenuate the mRNA expression of IL-1b
(Figure 4B). Similarly, ApxI-induced IL-8 mRNA expres-
sion was inhibited by p38 inhibitor up to ~85%, but not
by JNK inhibitor (Figure 4C). Distinguishably, both
p38 and JNK inhibitors blocked ApxI-induced TNF-a
mRNA expression by 92% and 54%, respectively
(Figure 4D). To confirm our findings, the cytokines
secreted from PAMs pre-treated with inhibitors and sti-
mulated with ApxI were also evaluated by quantitative
ELISA. In the presence of the p38 inhibitor, the protein
levels of IL-1b, IL-8 and TNF-a were significantly inhib-
ited by 69-95% compared to cells without inhibitor pre-
treatment and stimulated with ApxI (Figure 4E). Nota-
bly, the JNK inhibitor attenuated the protein level of
TNF-a, but not IL-1b or IL-8 (Figure 4E). These data
suggest that MAPK p38 plays a major role in ApxI-
induced IL-1b, TNF-a, and IL-8 expression, while JNK
participates only in ApxI-induced TNF-a expression.
b2 integrins mediate MAPK activation and subsequent
proinflammatory cytokine gene expression
The common subunit CD18 of b2 integrins is necessary
for A. pleuropneumoniae ApxIII-induced leukolysis [19].
To examine whether ApxI-induced MAPK activation was
attributable to ApxI-b2 integrin interaction, a blocking
antibody of porcine CD18 was applied to PAMs 1 h prior
to stimulation with 0.5 CU/mL ApxI and analyzed by
Western blot analysis. In the presence of CD18 antibody,
Figure 3 Protein levels of proinflammatory cytokines secreted from PAMs treated with ApxI. PAMs were stimulated with 1 CU/mL of
ApxI, heat-inactivated ApxI (Δ), or control medium (C) for 4 h. Subsequently, culture supernatants were collected and the protein levels of IL-1b
(A), IL-8 (B), TNF-a (C) and IL-6 (D) determined by ELISA. The results are the average of three independent experiments of triplicate
determinations. **p < 0.01; ***p < 0.001; n.s.: no significant difference from each other.
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ApxI-induced p38 activation was significantly inhibited
by 20-30% (Figure 5A). Cells treated with the control
medium or medium containing CD18 antibody displayed
only a basal level of phosphorylated p38. Similarly, block-
ing of CD18 on PAMs resulted in attenuation of ~65%
ApxI-activated JNK phosphorylation (Figure 5B). How-
ever, phosphorylated JNK was not observed in cells trea-
ted with the control medium or medium containing
CD18 antibody. Further, to evaluate the effect of ApxI-
b2 integrin interaction on cytokine mRNA expression,
PAMs were pre-incubated with CD18 antibody, stimu-
lated with 0.5 CU/mL ApxI for 2 h, and subjected to RT-
qPCR analysis. Blocking of CD18 molecule attenuated
IL-1b, IL-8 and TNF-a mRNA levels by 82-95%. Cells
treated with control medium or medium containing
CD18 antibody displayed similar basal levels of IL-1b,
IL-8 and TNF-a mRNA (Figure 5C). Collectively, these
results indicate CD18 plays a pivotal role in ApxI-
mediated MAPK activation and expression of proinflam-
matory cytokine genes in PAMs.
Discussion
Inflammation plays an essential role in respiratory
defense mechanism [26]. In porcine pleuropneumonia,
multiple components and virulence factors of A. pleur-
opneumoniae are suggested to contribute to the produc-
tion of proinflammatory cytokines [3]. Baarsch et al.
demonstrated alveolar lavage cells from pigs endotrache-
ally inoculated with a low-virulence strain of A. pleurop-
neumoniae serotype 1, i.e., lacking cytotoxic and
Figure 4 p38 and JNK mediate ApxI-induced proinflammatory cytokine production. (A) PAMs were stimulated with 0.5 CU/mL of ApxI,
heat-inactivated ApxI (Δ), or control medium (C) for 1 h. Subsequently, cells were lysed and subjected to Western blot analysis using an
antibody specific to phospho-p38 (p-p38) or phospho-JNK (p-JNK). (B-D) PAMs were pre-incubated with a p38 inhibitor SB203580 (SB), a JNK
inhibitor SP600125 (SP), or vehicle DMSO (V) for 1 h, followed by stimulation with 0.5 CU/mL ApxI for 2 h. PAMs were subjected to RT-qPCR
analysis for mRNA levels of IL-1b (B), IL-8 (C), and TNF-a (D). (E) PAMs were pre-incubated with SB, SP, or DMSO for 1 h, followed by stimulation
with 0.5 CU/mL of ApxI for 8 h. Subsequently, the culture supernatants were collected and the protein levels of IL-1b, IL-8, and TNF-a were
determined by ELISA. Data are representative of three independent experiments of at least triplicate determinations. ***p < 0.001.
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hemolytic activities, showed similar mRNA level of
TNF, IL-1 or IL-8 compared to buffer treated pigs [5].
Moreover, heat-treatment of crude A. pleuropneumo-
niae bacterial culture supernatant attenuated its ability
to induce TNF-a and IL-1 expression in porcine alveo-
lar macrophages (PAMs), suggesting heat-labile com-
ponents were involved in such stimulation [3]. In this
study, we present direct evidence demonstrating a sin-
gle species of exotoxin ApxI, derived from A. pleurop-
neumoniae serotype 10, induces the expression and
production of proinflammatory cytokines IL-1b, IL-
8 and TNF-a in PAMs.
Also, we found that, at low concentration such as 0.5 or
1 CU/mL, ApxI did not cause significant cell death
within 4 h, and > 68% of PAMs survived at 12 h of stimu-
lation (data not shown). Since alveolar macrophages are
one of the first line defense cells in lungs, at the early
stage of A. pleuropneumoniae infection, PAMs may be a
source of inflammatory mediators contributing to innate
immunity. Nevertheless, PAMs may not be the only
source of proinflammatory cytokines during A. pleurop-
neumoniae infection. For instance, Baarsch et al. demon-
strated expression of cytokine IL-6 in the lung tissue of
pigs inoculated with live A. pleuropneumoniae bacteria
[5]. However, fibroblasts and epithelial cells, but not
alveolar macrophages, might be the source of IL-6 [5].
This is consistent with our findings showing PAMs did
not express IL-6 upon ApxI stimulation. Therefore,
whether ApxI stimulates inflammatory cytokine IL-1b,
IL-8 or TNF-a in other cell types remains to be clarified.
Overproduction of proinflammatory mediators in
lungs can harm animals [26]. Based on our findings in
this study, it is tempting to hypothesize, in addition to
the hemolytic and cytolytic effects of ApxI, the toxin
may exacerbate lung damages caused by A. pleuropneu-
moniae through the induction of proinflammatory cyto-
kines. However, to avoid overemphasizing the effect of
ApxI, it should be noted that the cell wall component of
Gram negative bacteria, i.e., LPS, induces plethora
of inflammatory and immunological effects in various
cell types [34], such as TNF, IL-1 and IL-8 production by
porcine macrophages [35-37]. Moreover, Ramjeet et al.
had demonstrated that the cytotoxicity of ApxI and
ApxII was enhanced through interaction with LPS [38].
In our study, we found that in the absence of PMB, ApxI
preparation induced significantly higher levels of proin-
flammatory cytokine expression as compared to treat-
ment of ApxI in the presence of PMB (Figure 1A). These
findings indicate both LPS and ApxI are cytokine indu-
cing factors. However, whether LPS contributes to a
synergistic or additive effect on ApxI-induced cytokine
expression requires further investigation.
Mitogen-activated protein kinases (MAPKs) are
important signaling molecules involved in the expression
Figure 5 CD18 mediates p38 and JNK activation and
proinflammatory cytokine mRNA expression. (A and B) PAMs
were pre-incubated with CD18 blocking antibody (Anti-CD18) for 1
h prior to stimulation with 0.5 CU/mL ApxI or control medium (C)
for an additional 1 h. Thereafter, cells were lysed and subjected to
Western blot analysis with an antibody to phospho-p38 (p-p38) or
phospho-JNK (p-JNK). The average intensity of p-p38 or p-JNK
isoforms (p46 and p55) was quantified and normalized to the
intensity of b-actin (A and B, lower panel). (C) PAMs were pre-
incubated with anti-CD18 antibody and stimulated with 0.5 CU/mL
ApxI for 2 h, followed by RT-qPCR analysis of cytokine mRNA
expression. Data are representative of three independent
experiments of at least triplicate determinations.
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of inflammatory mediators in various types of cells
[21-25]. Upon MAPK activation, down-stream targets
including transcription factors are phosphorylated and
activated that in turn bind to the promoter region of
target genes [20]. Cooperative involvement of multiple
transcription factors is a common theme in the gene
regulation of single cytokine. It has been demonstrated
activating protein-1 (AP-1; consisting of heterodimers of
c-Jun, activating transcription factor-2 (ATF-2), c-Fos,
and Jun dimerization protein (JDP)), nuclear factor
kappa B (NF-B), and CAAT/enhancer-binding protein
(C/EBP) participate in transcriptional control of IL-
8 gene [21]. Similarly, the expression of TNF-a gene is
also regulated by C/EBP, NF-B, and AP-1 (c-Jun/ATF-
2) [39]. In addition, it is well-established MAPKs may
have overlapping substrate specificity on transcription
factors [20]. For example, c-Jun is phosphorylated
and activated specifically by JNK, while ATF-2 can be
phosphorylated by both JNK and p38 MAPKs
[33,40,41]. Nevertheless, the involvement of MAPKs in
RTX-induced cytokine gene expression has not been
identified.
In the present study, we showed both p38 and JNK
were substantially activated after ApxI stimulation, and
these two signaling molecules played differential regula-
tory roles in cytokine gene expression. Our observations
that p38 inhibitor (SB203580) attenuated the expression
of IL-1b, IL-8 and TNF-a, while JNK inhibitor
(SP600125) attenuated the expression only on TNF-a
gene, suggest p38 plays a more important role in ApxI-
induced IL-1b, IL-8 and TNF-a expression. These find-
ings are similar to previous studies showing
SB203580 inhibited gene expression of IL-1b, IL-8 and
TNF-a [21,23,25], while SP600125 inhibited gene expres-
sion of TNF-a, but not IL-1b or IL-8 [42]. However, the
question of which transcription factors are involved in
ApxI-induced cytokine expression and the regulatory
role of MAPKs on these factors remain to be determined.
CD18 of b2 integrins has been proposed as a receptor
for ApxIII-mediated leukolysis [19]. In this study, the
observations that blocking of CD18 on PAMs resulted
in attenuation of ApxI-induced p38 and JNK activation
and subsequent cytokine gene expression suggest ApxI-
b2 integrin interaction contributes to these events.
Nevertheless, current knowledge of signaling pathways
underlying b2 integrin-induced MAPK activation is very
limited. Studies by Hsuan et al. indicated M. haemoly-
tica Lkt-induced intracellular [Ca2+] ([Ca2+]i) elevation
in bovine alveolar macrophages is mediated through a
G-protein-coupled mechanism [18], and [Ca2+]i eleva-
tion is crucial for proinflammatory cytokine gene
expression [9]. Consequently, a study by Jeyaseelan et al.
demonstrated Lkt-induced [Ca2+]i elevation depends on
LFA-1 [14]. It has been reported MAPKs are activated
by a small G-protein Ras downstream G-protein-
coupled receptor (GPCR) signaling pathway [20,43]. The
question of whether ApxI-induced MAPK activation
also occurs through a calcium-dependent, G-protein-
coupled mechanism leading to cytokine gene expression
requires further investigation.
In summary, this study provides evidence demonstrat-
ing ApxI is able to induce the expression of proinflam-
matory cytokines IL-1b, IL-8 and TNF-a in porcine
alveolar macrophages. This is the first report to demon-
strate p38 and JNK play differential regulatory roles in
ApxI-induced cytokine gene expression through a
CD18-dependent pathway.
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